mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-05 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-05 |